Early research (Phase 1)Study completedNCT01219348What this trial is testingIDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.Who this might be right forNSCLCLung Cancer Inge Marie Svane 14
Testing effectiveness (Phase 2)Study completedNCT00815321What this trial is testingAutologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug TherapyWho this might be right forChronic Myeloid Leukemia Singapore General Hospital 11
Large-scale testing (Phase 3)Active Not RecruitingNCT06732401What this trial is testingTesting the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung CancerWho this might be right forLung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more National Cancer Institute (NCI) 630
Not applicableActive Not RecruitingNCT07046195What this trial is testingOptimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast CancerWho this might be right forHypofractionated RadiotherapyTriple Negative Breast Cancer (TNBC)Immunotherapy Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT05726864What this trial is testingELI-002 7P in Subjects With KRAS/NRAS Mutated Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaColorectal CancerKRAS G12D+11 more Elicio Therapeutics 158
Not applicableActive Not RecruitingNCT07009470What this trial is testingA Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for RecurrenceWho this might be right forHCC Tongji Hospital 130
Large-scale testing (Phase 3)Active Not RecruitingNCT02362594What this trial is testingStudy of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)Who this might be right forMelanoma Merck Sharp & Dohme LLC 1,019
Testing effectiveness (Phase 2)Study completedNCT02261714What this trial is testingAntigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic CancerWho this might be right forPancreatic Cancer, Resected Targovax ASA 32
Testing effectiveness (Phase 2)Study completedNCT01627678What this trial is testingImmunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ARTWho this might be right forHIV-1 Infection Bionor Immuno AS 36
Very early researchStudy completedNCT01425749What this trial is testingStudy to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCIWho this might be right forMelanoma Craig L Slingluff, Jr 25
Testing effectiveness (Phase 2)Temporarily pausedNCT05642195What this trial is testingEvaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung CancerNon-Small Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung+1 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00365872What this trial is testingExternal Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for SarcomaWho this might be right forSoft Tissue Sarcoma H. Lee Moffitt Cancer Center and Research Institute 17
Testing effectiveness (Phase 2)UnknownNCT05761132What this trial is testingNeo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept StudyWho this might be right forVulva CancerVulva NeoplasmSquamous Cell Cancer Leiden University Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT01506375What this trial is testingSafety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating AdjuvantWho this might be right forHay Fever BioTech Tools S.A. 24
Not applicableEnrolling By InvitationNCT06997913What this trial is testingAdjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma（AICRC）Who this might be right forLymph Node MetastasisNeurovascular InvasionPathology Showed R1 Resection Hengchao Yu 10
Large-scale testing (Phase 3)Active Not RecruitingNCT05587374What this trial is testingCadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)Who this might be right forNasopharyngeal CarcinomaNasopharyngeal Cancer Sun Yat-sen University 490
Testing effectiveness (Phase 2)UnknownNCT03925090What this trial is testingPhase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC PatientsWho this might be right forNasopharyngeal Carcinoma Sun Yat-sen University 150
Large-scale testing (Phase 3)Ended earlyNCT00126178What this trial is testingClinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney CancerWho this might be right forKidney CancerRenal Cell Carcinoma Agenus Inc. 600
Testing effectiveness (Phase 2)Looking for participantsNCT07167160What this trial is testingChemo-immunotherapy for Cervical Cancer Stage IIICp TrialWho this might be right forCervical CancerImmunochemotherapy Women's Hospital School Of Medicine Zhejiang University 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT06045975What this trial is testingDurvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation ProcedureWho this might be right forHCC - Hepatocellular Carcinoma Assistance Publique - Hôpitaux de Paris 30